Education
About Us
Working with TipRanks
Follow Us
dorsaVi Limited (AU:DVL)
:DVL
DVL Stock Chart & Stats
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.02
Previous CloseN/A
Volume925.00K
Average Volume (3M)329.83K
Market Cap
AU$5.12M
Enterprise ValueAU$6.48M
Total Cash (Recent Filing)AU$4.87M
Total Debt (Recent Filing)AU$427.26K
Price to Earnings (P/E)―
Beta-0.29
Next Earnings
Aug 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding731,237,900
10 Day Avg. Volume337,390
30 Day Avg. Volume329,829
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.35
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
dorsaVi Limited News
PremiumCompany Announcements
dorsaVi Unveils Revolutionary 3D Motion Analysis to Combat ACL Injuries
PremiumCompany Announcements
dorsaVi Partners with Renowned US Surgeon for Athlete Movement Study
PremiumCompany Announcements
dorsaVi Limited Announces Cessation of Securities
PremiumCompany Announcements
dorsaVi Partners with Secret Network for Privacy Innovation
PremiumCompany Announcements
dorsaVi Launches AI-Powered Movement Analysis Platform
PremiumCompany Announcements
dorsaVi Limited Welcomes New Director Leigh Travers
PremiumCompany Announcements
dorsaVi Welcomes Blockchain Expert to Board---
Options Prices
Currently, No data available
---
Ownership Overview
5.90% Insiders
―
Mutual Funds
― Other Institutional Investors
94.10% Public Companies and
Individual Investors
DVL FAQ
What was dorsaVi Limited’s price range in the past 12 months?
dorsaVi Limited lowest share price was <AU$0.01 and its highest was AU$0.02 in the past 12 months.
What is dorsaVi Limited’s market cap?
dorsaVi Limited’s market cap is AU$5.12M.
When is dorsaVi Limited’s upcoming earnings report date?
dorsaVi Limited’s upcoming earnings report date is Aug 27, 2025 which is in 143 days.
How were dorsaVi Limited’s earnings last quarter?
dorsaVi Limited released its earnings results on Feb 26, 2025. The company reported -AU$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.001.
Is dorsaVi Limited overvalued?
According to Wall Street analysts dorsaVi Limited’s price is currently Overvalued.
Does dorsaVi Limited pay dividends?
dorsaVi Limited does not currently pay dividends.
What is dorsaVi Limited’s EPS estimate?
dorsaVi Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does dorsaVi Limited have?
dorsaVi Limited has 731,237,900 shares outstanding.
What happened to dorsaVi Limited’s price movement after its last earnings report?
dorsaVi Limited reported an EPS of -AU$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of dorsaVi Limited?
Currently, no hedge funds are holding shares in AU:DVL
---
dorsaVi Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:DVL Sentiment 70%
Sector Average 65%
Sector Average 65%
Insider Transactions
Bought Shares
Worth AU$95.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
―
20 days / 200 days
Momentum
-23.07%
12-Months-Change
Fundamentals
Return on Equity
-74.01%
Trailing 12-Months
Asset Growth
6.62%
Trailing 12-Months
Company Description
dorsaVi Limited
dorsaVi Ltd engages in the development and sale of motion analysis technologies in Australia, Europe, and the United States. The company provides ViMove+, a clinical and sports solutions; ViSafe, a wearable sensor technology that tracks, analyzes, and reports how workforce moves and reviews and pinpoints unsafe work practices that leads to workplace injury; and myViSafe technology for organizations and on-site clinicians to identify and mitigate injury risk in the workplace and drive behavioral changes. It also offers ViPerform, a wearable and wireless movement sensor technology that offers objective data to assess risk of sport injury, and guides athletic training and recovery programs; telehealth solutions; and professional suites. dorsaVi Ltd was incorporated in 2008 and is based in Oakleigh South, Australia.
---
Technical Analysis
Impedimed Limited
―
PYC Therapeutics Limited
―
Resonance Health Ltd
―
Race Oncology Ltd.
―
Botanix Pharmaceuticals Limited
―
---